Preferred Label : Ectodermal dysplasia and immunodeficiency 2;
Symbol : EDAID2;
CISMeF acronym : EDAID2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Ectodermal dysplasia, anhidrotic, with t-cell immunodeficiency, autosomal dominant; Ectodermal dysplasia, hypohidrotic, with immunodeficiency 2; Ectodermal dysplasia, anhidrotic, with immunodeficiency 2;
Description : Mutations in the NFKBIA gene result in functional impairment of NFKB1 (164011), a
master transcription factor required for normal activation of immune responses. Interruption
of NFKB1 signaling results in decreased production of proinflammatory cytokines and
certain interferons, rendering patients susceptible to infection (McDonald et al.,
2007).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the nuclear factor kappa-B inhibitor, alpha gene (NFKBIA, 164008.0001);
Prefixed ID : #612132;
Origin ID : 612132;
UMLS CUI : C2677481;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT